Search

Memorial Sloan Kettering Cancer Center, along with five other elite academic institutions, will share an unprecedented total of $540 million in new financial support from Ludwig Cancer Research.

… Monday, January 6, 2014 Ludwig Center at Memorial Sloan Kettering Receives $90 Million in Funding For Cancer Research Memorial Sloan Kettering Cancer Center, along with five other elite academic institutions, will share an unprecedented total of $540 million in new financial support from Ludwig Cancer

MSK experts discuss risk factors, symptoms, and treatment for male breast cancer.

… Monday, September 26, 2022 Breast cancer in men accounts for less than 1% of all cases of breast cancer . But because breast cancer is so common, that still amounts to about 2,700 cases in the United States every year. The current treatments for men with breast cancer are largely based on what doctors

Sequencing advanced endometrial tumors with the MSK-IMPACT™ assay provides an effective method for detecting microsatellite instability (MSI) and germline cancer predisposition syndromes

… Thursday, December 13, 2018 Sequencing advanced endometrial tumors with the MSK-IMPACT™ assay provides an effective method for detecting microsatellite instability (MSI) and germline cancer predisposition syndromes, which are collectively present in 16 percent of patients, as well as potentially actionable

New MSK research illuminates new details about Thetis cells that will support efforts to harness them therapeutically; shows how the timing and strength of danger signals steer immune cell fates; and employs single-nucleus DNA sequencing to shed new light on the evolution of pancreatic cancer.

… Wednesday, February 4, 2026   New research from Memorial Sloan Kettering Cancer Center (MSK) illuminates new details about Thetis cells that will support efforts to harness them therapeutically; shows how the timing and strength of danger signals steer immune cell fates; and employs single-nucleus DNA

Everolimus plus bevacizumab demonstrates robust activity in treatment-naïve patients with advanced papillary variant nonclear cell renal cell carcinoma.

… Monday, November 9, 2020 Everolimus plus bevacizumab demonstrates robust activity in treatment-naïve patients with advanced papillary variant nonclear cell renal cell carcinoma (nccRCC), according to the results of an expanded single-arm, single-institution phase II trial conducted at Memorial Sloan

Learn how to get enough calories during treatment from MSK specialists in diet and nutrition.

… Tuesday, January 15, 2019 Summary MSK experts offer tips on how people who are currently in cancer treatment can get enough vital calories when they need them most. During cancer treatment, many people face a nutritional double whammy. The disease can rob them of their appetite and sap their strength

BCG has been used to treat bladder cancer for more than 30 years. Scientists are still learning how it works.

… Friday, July 17, 2020 Summary Scientists at Memorial Sloan Kettering have found that BCG, a commonly used immunotherapy for bladder cancer , works differently than many researchers had assumed. For people with early-stage bladder cancer, an immunotherapy called BCG has been the standard treatment for

… Friday, September 30, 2022 The idea came to Swathi Iyer on the subway, while headed to a Broadway show: The best way to explain brain cancer’s need for cholesterol is to liken it to an addiction. And the processes that regulate cholesterol activity present in normal brain cells are like the local police

Pharmacist and herbalist Simon Yeung gives consumers tips on how to determine whether an herb or dietary supplement contains what’s indicated on the label.

… Friday, January 17, 2014 Summary Pharmacist and herbalist Simon Yeung gives consumers tips on how to determine whether an herb or dietary supplement contains what’s indicated on the label. Many people search the web, ask friends and family, or look in reference books when they want to know if an herb

Two brothers discuss their surprise at being diagnosed with Lynch syndrome.

… Thursday, July 19, 2018 Summary One man’s cancer diagnosis spurs his brother to undergo more frequent cancer screenings, a decision that may have saved his life. When his younger brother, Mitchell, was found to have urothelial cancer in 2011, Elliot Katz never expected that diagnosis might save his own